Richard A. Larson to Quality-Adjusted Life Years
This is a "connection" page, showing publications Richard A. Larson has written about Quality-Adjusted Life Years.
Connection Strength
0.032
-
Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States. J Natl Cancer Inst. 2016 Jul; 108(7).
Score: 0.032